Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | ethoxyquin | 27447 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | ethoxyquin | 27447 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | ethoxyquin | 27447 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | ethoxyquin | 27447 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | ethoxyquin | 27447 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | piperacillin | 10649 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | piperacillin | 10649 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | piperacillin | 10649 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | piperacillin | 10649 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | piperacillin | 10649 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | piperacillin | 10649 | drug-path |
Asthma | R-HSA-444620 | map05310 | piperacillin | 10649 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | piperacillin | 10649 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | piperacillin | 10649 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | piperacillin | 10649 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | piperacillin | 10649 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | spiramycin | 5289394 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | spiramycin | 5289394 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | spiramycin | 5289394 | drug-path |
Adherens junction | R-HSA-451386 | map04520 | spiramycin | 5289394 | drug-path |